Sargent Investment Group »

Relmada Therapeutics shares owned by Sargent Investment Group

Quarter-by-quarter ownership of Relmada Therapeutics (RLMD) shares owned by Sargent Investment Group from 13F filings

Historical chart of Sargent Investment Group investment in Relmada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Relmada Therapeutics held by Sargent Investment Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Relmada Therapeutics by Sargent Investment Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $102k 22k 4.65
2023-09-30 $49k 16k 3.00
2023-06-30 $41k 17k 2.46
2023-03-31 $34k 14k 2.37